OBJECTIVE: Examine the cost-effectiveness of a 3-week interdisciplinary pediatric chronic pain rehabilitation program. METHODS: Self-reported health care utilization and parent missed work of youth with chronic pain (n = 127) at admission and 1-year follow-up were compared. Financials were calculated from program revenue and established national costs for health care and wages. RESULTS: Data indicate significant reductions in days hospitalized, physician office visits, physical/occupational therapy services, psychotherapy visits, and parental missed work. Estimated health care expenses were $61,988 in the year before admission and $14,189 in the year after admission (-$58,839). Estimated cost of missed work was $12,229 in the year prior and $1,189 in the year after (-$11,039). CONCLUSIONS: Comparing estimated expenses before ($74,217) and after ($15,378) minus program costs ($31,720), yielded estimated savings of $27,119 per family in the year following admission. These findings extend the benefit of the program beyond clinical improvement, to outcomes important to both families and insurers.
OBJECTIVE: Examine the cost-effectiveness of a 3-week interdisciplinary pediatric chronic pain rehabilitation program. METHODS: Self-reported health care utilization and parent missed work of youth with chronic pain (n = 127) at admission and 1-year follow-up were compared. Financials were calculated from program revenue and established national costs for health care and wages. RESULTS: Data indicate significant reductions in days hospitalized, physician office visits, physical/occupational therapy services, psychotherapy visits, and parental missed work. Estimated health care expenses were $61,988 in the year before admission and $14,189 in the year after admission (-$58,839). Estimated cost of missed work was $12,229 in the year prior and $1,189 in the year after (-$11,039). CONCLUSIONS: Comparing estimated expenses before ($74,217) and after ($15,378) minus program costs ($31,720), yielded estimated savings of $27,119 per family in the year following admission. These findings extend the benefit of the program beyond clinical improvement, to outcomes important to both families and insurers.
Authors: Andrew M Youssef; Ke Peng; Pearl Kijoo Kim; Alyssa Lebel; Navil F Sethna; Corey Kronman; David Zurakowski; David Borsook; Laura E Simons Journal: Neurobiol Pain Date: 2021-02-19
Authors: Hilary A Marusak; Allesandra S Iadipaolo; Cindy Cohen; Elimelech Goldberg; Jeffrey W Taub; Felicity W K Harper; Martin H Bluth; Christine A Rabinak Journal: J Pain Res Date: 2020-12-29 Impact factor: 3.133
Authors: Laura E Simons; Christine B Sieberg; Caitlin Conroy; Edin T Randall; Julie Shulman; David Borsook; Charles Berde; Navil F Sethna; Deirdre E Logan Journal: J Pain Date: 2017-12-06 Impact factor: 5.820